Skip to content

Clinical trials

Multiple Sclerosis, Chronic Progressive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Country / region: Canada Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20101
20112
20122
20152
20163
20171
20182
20193
20203
20212
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting6
Terminated5
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Novartis Pharmaceuticals4
University of Calgary3
Eli Lilly and Company2
Hicks, Audrey, Ph.D.2
Sanofi2
AbbVie1
Atara Biotherapeutics1
Biogen1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive29
Multiple Sclerosis14
Fatigue2
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Cognitive Dysfunction1
Demyelinating Diseases1
Disease Progression1
Epstein-Barr Virus Infections1
Inflammation1

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.